Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is headquartered in Espoo, Etela-Suomen and currently employs 4,030 full-time employees. The company went IPO on 2006-07-03. The firm is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
Orion Oyj hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü altı ayda bir ödenmektedir ve son temettü hariç tarihi Oct 16, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.94
Oct 16, 2025
Ödeme Sıklığı
Ödeme Oranı
Altı ayda bir
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Oct 16, 2025
$0.4749
Oct 16, 2025
Nov 7, 2025
Apr 7, 2025
$0.4638
Apr 7, 2025
Apr 29, 2025
Oct 16, 2024
$0.4357
Oct 16, 2024
Nov 7, 2024
Mar 21, 2024
$0.4375
Mar 22, 2024
Apr 18, 2024
Mar 23, 2023
$0.8699
Mar 24, 2023
Apr 17, 2023
Mar 24, 2022
$0.8282
Mar 25, 2022
Apr 18, 2022
Dividend Grafikleri
ORINY Kâr Payları
ORINY Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Orion Oyj'in şu anki temettü ödemesi ve yıllık temettüsü nedir?